SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs and Pharmaceuticals informs about un-audited financial results

26 Jul 2017 Evaluate

Welcure Drugs and Pharmaceuticals has informed that the Board of Directors of the Company has approved the Un-Audited Financial Results for the Quarter ended 30.06.2017.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

0.31 0.00 (0.00%)
24-Apr-2026 12:53 View Price Chart
Peers
Company Name CMP
Redington 215.50
Adani Enterprises 2237.00
Amrapali Industries 17.69
Rashi Peripheral 458.90
PDS 278.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×